Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Immunodeficiency Diseases

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[A 3-week history of intestinal symptoms in a 67-year-old male patient with chronic arthralgia].

Der Internist·2020

Same author

[Upper abdominal pain and febrile episodes in a 44-year-old Filipino woman].

Der Internist·2017

Same author

[Leukopenia with unclear fever].

Der Internist·2017

Same author

Embracing an era of rising family quality of life research.

Journal of intellectual disability research : JIDR·2011

Same author

[48-year-old female patient with Crohn's disease and new hematuria and proteinuria].

Der Internist·2010

Same author

[Management of iatrogenic esophageal perforations].

HNO·2006

Search research articles

Related Experiment Video

Updated: May 18, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

[Unclear tetraparesis under immunosupression].

T Kündiger¹, R Kober, E Wegjan

¹Medizinische Klinik mit Schwerpunkt Gastroenterologie, Sana Kliniken Düsseldorf GmbH, Deutschland. thomas.kuendiger@sana.de

|September 6, 2012

Summary

A 69-year-old man developed severe muscle weakness and pain while on prednisolone. He was diagnosed with Staphylococcus aureus pyomyositis and sepsis, which improved with antibiotics.

Related Experiment Videos

Last Updated: May 18, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

Area of Science:

Infectious Diseases
Neurology
Rheumatology

Background:

Pyomyositis is a bacterial infection of skeletal muscle, typically seen in tropical regions.
Immunodeficiency can predispose individuals to pyomyositis, even in non-tropical climates.
Prolonged corticosteroid therapy, like with prednisolone, can lead to immunosuppression.

Observation:

A 69-year-old male patient presented with tetraparesis and myalgia after several months of prednisolone treatment.
The patient was diagnosed with sepsis secondary to pyomyositis, complicated by Staphylococcus aureus septic pulmonary abscesses.

Findings:

Antibiotic treatment with piperacillin and tazobactam led to reduced inflammatory markers.
The patient experienced significant improvement in his tetraparesis following antibiotic therapy.

Implications:

This case highlights the potential for pyomyositis in immunocompromised patients, including those on long-term corticosteroids, in temperate climates.
Early diagnosis and appropriate antibiotic management are crucial for favorable outcomes in severe pyomyositis cases.
Physicians should consider pyomyositis in patients with unexplained muscle weakness and pain, especially if they have risk factors for immunosuppression.